1. "Mark Robson"
  2. "Division of Subspecialty Medicine "
Formats
  1. Journal Article (20)
  2. Meeting Abstract (15)
Groups
  1. Breast Medicine Service (35)
  2. Department of Medicine (35)
  3. Division of Subspecialty Medicine (35)
  4. Population Sciences Research Program (35)
  5. Solid Tumor Oncology Division (35)
  6. Survivorship Research (35)

More Groups

People
  1. Mark Robson (35)
  2. Zsofia Stadler (18)
  3. Kenneth Offit (16)
  4. Erin Salo-Mullen (13)
  5. Andrew Seidman (8)
  6. Arnold Markowitz (8)

More People

Years
  1. 2023 (3)
  2. 2022 (2)
  3. 2021 (2)
  4. 2020 (5)
  5. 2019 (2)
  6. 2018 (4)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. Cancer Research (3)
  3. Breast Cancer Research and Treatment (2)
  4. Cancer (2)
  5. Annals of Behavioral Medicine (1)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (12)
  2. American Association for Cancer Research (6)
  3. Springer (4)
  4. Oxford University Press (3)
  5. Elsevier Inc. (2)
  6. Wiley Blackwell (2)

More Publishers

Results (35)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study
    Journal Article

    Nagaraj, G.; Vinayak, S.; Khaki, A. R.; Sun, T.; Kuderer, N. M.; Aboulafia, D. M.; Acoba, J. D.; Awosika, J.; Bakouny, Z.; Balmaceda, N. B.; more...
    eLife (2023)

    Fulltext@MSK | Save
  • Electro-acupuncture versus battle field auricular acupuncture in breast cancer survivors with chronic musculoskeletal pain: Subgroup analysis of a randomized clinical trial
    Journal Article

    Bao, T.; Zhi, W. I.; Baser, R. E.; Li, Q. S.; Weitzman, M.; Gillespie, E. F.; Robson, M.; Mao, J. J.
    Breast Cancer Research and Treatment (2023)

    Fulltext@MSK | Save
  • Older patients with early-stage triple-negative breast cancer: The Memorial Sloan Kettering Cancer Center experience
    Meeting Abstract

    Zhi, I.; Lake, D. E.; Ehrich, F.; Chen, Y.; Korc-Grodzicki, B.; Norton, L.; Robson, M. E.; Singh, J. C.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Interim analysis of a single-center, single-arm, prospective phase 2 study to evaluate the efficacy and safety of benralizumab for alpelisib rash in metastatic PIK3CA-mutant, hormone receptor-positive breast cancer
    Meeting Abstract

    Lacouture, M. E.; Pan, A.; Dranitsaris, G.; Harris, U.; Chandarlapaty, S.; Dang, C. T.; Gajria, D.; Gordon, A.; Iyengar, N. M.; Robson, M. E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Interest and utility of MC1R testing for melanoma risk in dermatology patients with a history of nonmelanoma skin cancer
    Journal Article

    Hay, J. L.; Christian, S. N.; Schofield, E.; Hamilton, J. G.; Yang, C.; Hedayati, B.; Sadeghi, K.; Robson, M. E.; Halpern, A.; Zhang, L.; more...
    Journal of Skin Cancer (2022)

    Fulltext@MSK | Save
  • A comprehensive comparison of early-onset and average-onset colorectal cancers
    Journal Article

    Cercek, A.; Chatila, W. K.; Yaeger, R.; Walch, H.; Dos Santos Fernandes, G.; Krishnan, A.; Palmaira, L.; Maio, A.; Kemel, Y.; Srinivasan, P.; more...
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save
  • Prevalence and characterization of biallelic and monoallelic NTHL1 and MSH3 variant carriers from a pan-cancer patient population
    Journal Article

    Salo-Mullen, E. E.; Maio, A.; Mukherjee, S.; Bandlamudi, C.; Shia, J. R.; Kemel, Y.; Cadoo, K. A.; Liu, Y.; Carlo, M.; Ranganathan, M.; more...
    JCO Precision Oncology (2021)

    Fulltext@MSK | Save
  • Germline mutation prevalence in young adults with cancer
    Meeting Abstract

    Stadler, Z. K.; Maio, A.; Padunan, A.; Kemel, Y.; Salo-Mullen, E.; Sheehan, M.; Belanfanti, K.; Tejada, P. R.; Birsoy, O.; Mandelker, D.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors
    Journal Article

    Razavi, P.; Dickler, M. N.; Shah, P. D.; Toy, W.; Brown, D. N.; Won, H. H.; Li, B. T.; Shen, R.; Vasan, N.; Modi, S.; more...
    Nature Cancer (2020)

    Fulltext@MSK | Save
  • Yoga for chemotherapy-induced peripheral neuropathy and fall risk: A randomized controlled trial
    Journal Article

    Bao, T.; Zhi, I.; Baser, R.; Hooper, M.; Chen, C.; Piulson, L.; Li, Q. S.; Galantino, M. L.; Blinder, V.; Robson, M.; more...
    JNCI Cancer Spectrum (2020)

    Fulltext@MSK | Save